MithraGen Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

MithraGen General Information

Description

Developer of immunotherapies for T and B cells for the treatment and prevention of cancers and infectious diseases. The company develops immunotherapies incorporating Class I and II restricted epitopes for the treatment of cancers and infectious diseases that currently have no satisfactory therapy.

Contact Information

Website
www.mithragen.com
Formerly Known As
MithraTech
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 8030 El Rio
  • Houston, TX 77054
  • United States
+1 (713) 000-0000
Primary Industry
Biotechnology
Acquirer
Northwest Biotherapeutics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 8030 El Rio
  • Houston, TX 77054
  • United States
+1 (713) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MithraGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Jan-2008 00.000 Completed Generating Revenue
3. Early Stage VC (Series B) 12-Mar-2004 00.00 00.000 00.000 Completed Startup
2. Early Stage VC (Series A) $1.89M $1.89M 00.00 Completed
1. Accelerator/Incubator Completed Startup
To view MithraGen’s complete valuation and funding history, request access »

MithraGen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 000,000 00.000000 00.00 00 00 00 00 00.000
To view MithraGen’s complete cap table history, request access »

MithraGen Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BCM Ventures Venture Capital Minority 000 0000 000000 0
Emerging Technology Partners (Venture Capital) Corporate Venture Capital Minority 000 0000 000000 0
Wake Forest Baptist Corporation 000 0000 000000 0
To view MithraGen’s complete investors history, request access »

Ready to get started?

Request a free trial

MithraGen FAQs

  • When was MithraGen founded?

    MithraGen was founded in 2000.

  • Who is the founder of MithraGen?

    Si-Yi Chen Ph.D is the founder of MithraGen.

  • Where is MithraGen headquartered?

    MithraGen is headquartered in Houston, TX.

  • What industry is MithraGen in?

    MithraGen’s primary industry is Biotechnology.

  • Is MithraGen a private or public company?

    MithraGen is a Private company.

  • What is MithraGen’s current revenue?

    The current revenue for MithraGen is 00000.

  • How much funding has MithraGen raised over time?

    MithraGen has raised $3.99M.

  • Who are MithraGen’s investors?

    BCM Ventures, Emerging Technology Partners (Venture Capital), and Wake Forest Baptist have invested in MithraGen.

  • When was MithraGen acquired?

    MithraGen was acquired on 01-Jan-2008.

  • Who acquired MithraGen?

    MithraGen was acquired by Northwest Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »